BOSTON (Reuters) – Fidelity Investments Chief Executive Officer Abigail Johnson is betting part of her personal fortune on several companies developing cancer treatments, including three that have recently announced plans for initial public offerings.
No bird soars too high, if it soars with its own wings… — Friedrich Nietzsche
